Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Celsius Holdings (CELH) yesterday and set a price target of $26.00. The company’s shares closed last Friday at $20.99, close to its 52-week high of $21.00.
According to TipRanks.com, Vendetti is a 5-star analyst with an average return of 9.3% and a 48.4% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Milestone Scientific, Ra Medical Systems, and Sensus Healthcare.
Celsius Holdings has an analyst consensus of Strong Buy, with a price target consensus of $25.38, which is a 20.9% upside from current levels. In a report issued on July 28, B.Riley FBR also reiterated a Buy rating on the stock with a $17.00 price target.
See today’s analyst top recommended stocks >>
Based on Celsius Holdings’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $28.18 million and net profit of $546.1K. In comparison, last year the company earned revenue of $14.49 million and had a net profit of $11.66 million.
Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of calorie-burning beverages. It offers flavors including grapefruit, cucumber lime, orange pomegranate, pineapple coconut, watermelon berry, and strawberries and cream. The company was founded in April 2004 and is headquartered in Boca Raton, FL.
